相关实验视频
Updated: Jun 18, 2025
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.6K
灰质中的NODDI是衰老和早期AD变化的敏感标志物
Xi Yu1, Scott A Przybelski2, Robert I Reid2,3
1Department of Physiology and Biomedical Engineering Mayo Clinic Rochester Minnesota USA.
Alzheimer's & dementia (Amsterdam, Netherlands)
|July 30, 2024
概括
神经元定向分散和密度成像 (NODDI) 显示出作为大脑健康生物标志物的前景. 它的自由水分量 (FWF) 测量比传统方法对正常大脑衰老和早期阿尔茨海默病 (AD) 变化更为敏感.
科学领域:
- 神经成像是一种神经成像.
- 生物标志物发现发现
- 神经退行性疾病 神经退行性疾病
背景情况:
- 与年龄相关的神经退行和阿尔茨海默病 (AD) 影响大脑健康.
- T1加权的形态测量是已知的生物标志物,但可能缺乏对早期变化的敏感性.
- 神经元定向分散和密度成像 (NODDI) 提供了生物学上有意义的微观结构见解.
研究的目的:
- 为了对比NODDI和形态测量对衰老和早期AD的敏感性.
- 评估与年龄,临床诊断和病理学的相关性.
- 建立NODDI作为一个先进的大脑健康生物标志物.
主要方法:
- 区域灰色物质分析.
- 对NODDI和形态测量评估进行比较.
- 与年龄,临床阶段和AV1451 tau PET的相关性分析.
主要成果:
- 与形态测量相比,NODDI测量表明对衰老和早期AD变化的敏感性更高.
- 自由水分数 (FWF),NODDI输出,对与年龄相关的变化表现出更大的敏感性.
- FWF与区域性陶沉积有更强的关联,并且可以更好地区分轻度认知障碍和认知正常的个体.
结论:
- NODDI是检测早期神经退行变化的宝贵工具.
- FWF是正常大脑衰老和早期AD病理学的敏感指标.
- 诺迪提升了对衰老和阿尔茨海默病进展的理解.
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K